← К результатам

Biomed Res Int · 2022

Advances in CRISPR/Cas9.

BioMed research international, 2022: 9978571 PMID 36193328 DOI 10.1155/2022/9978571

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

CRISPR/Cas9 technology has become the most examined gene editing technology in recent years due to its simple design, yet low cost, high efficiency, and simple operation, which can also achieve simultaneous editing of multiple loci. It can also be carried out without using plasmids, saving lots of troubles caused by plasmids. CRISPR/Cas9 has shown great potential in the study of genes or genomic functions in microorganisms, plants, animals, and human beings. In this review, we will examine the history, structure, and basic mechanisms of the CRISPR/Cas9 system, describe its great value in precision medicine and sgRNA library screening, and dig its great potential in a new field: DNA information storage.

Цитирование